What Role Do New Therapies Play in TTP Treatment?
While plasma exchange remains the foundation of acute TTP treatment, new therapies are improving outcomes and reducing relapse. The most significant recent advance is caplacizumab, a nanobody that blocks the interaction between von Willebrand factor and platelets, preventing clot formation even before ADAMTS13 levels recover. When used alongside plasma exchange and immunosuppression,...
0 Comentários 0 Compartilhamentos 219 Visualizações 0 Anterior